Type 1 diabetes (T1D) is one of the most common incurable autoimmune diseases. Insulin is the major target for T1D in humans and rodents. A single polymorphism at β57 in major histocompatibility complex class II (MHCII) molecules is associated with We suggest that diabetogenic T cells escape elimination during thymic development because they recognize epitopes uniquely generated in the pancreas by modifications to the C-terminus of this insulin peptide. These results open up the possibility of new target to develop diagnostic and therapeutic reagents for human T1D.
